Esketamine Timing Matters: Pre-Extubation Dosing Cuts Emergence Agitation After Nasal Surgery
This small single-center trial suggests that when subanesthetic esketamine is given, not just whether it is given, determines its protection against emergence agitation, a question that bears directly on perioperative protocol design.
📅 Journal publication: 2026(online Oct 28, 2026)·Last updated: Nov 16, 2026
Esketamine timing crucial for reducing anesthesia-related agitation.
Emergence agitation (EA) is common after anesthesia, impacting recovery quality. Administration of esketamine 20 minutes before surgery reduced EA incidence to 9.7% compared to 40.6% with placebo. Single-center findings suggest timing of esketamine administration is crucial, but require multicenter validation. Administering esketamine before surgery's end can significantly reduce emergence agitation.
📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Free account, no credit card. Includes 1 full deep analysis every month.
Authors:Wen X, Sun W, Chen W, Guo L, Zhang Y, Lv S, Liu Y, Qiu Z
Citation:Wen X, Sun W, Chen W, et al. Impact of administration timing of subanesthetic doses of esketamine on emergence agitation in patients undergoing nasal endoscopic surgery: a randomized controlled trial. Frontiers in medicine. 2026;13:1978040. doi:10.3389/fmed.2026.1978040